Voltar
Carta Acesso aberto Revisado por pares
BIBTEX RIS

Safety in Overdose of Mirtazapine

1997; Physicians Postgraduate Press, Inc.; Volume: 58; Issue: 6 Linguagem: Inglês

10.4088/jcp.v58n0607a

ISSN

1555-2101

Autores

Anthony W. Gerritsen,

Tópico(s)

Epilepsy research and treatment

Resumo

Article AbstractLetter to the Editor Sir: The new antidepressant mirtazapine (Remeron) has a unique mode of action, combining an increase of noradrenergic and 5-HT1A-mediated serotonergic neurotransmission with a specific blockade of 5-HT2 and 5-HT3-receptor subtypes. So far, a single case of overdose with mirtazapine has been reported since its introduction in The Netherlands in September 1994; I now report the second case.

Referência(s)